Bicyclic Heterocyclic Compounds As Fgfr Inhibitors

Abstract

The invention relates to new bicyclic heterocyclic derivative compounds, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.


Claims
Applicants

Sign in to the Lens

Feedback